|Day Low/High||1.71 / 1.79|
|52 Wk Low/High||1.25 / 3.68|
-- Management to host conference call today at 8:30 a.m. EDT --
Spectrum Pharmaceuticals, BioCryst Pharmaceuticals and Curis were among the biotech stock movers in premarket trading on Thursday.
Loncar Investments, LLC today announced the result of the semi-annual rebalance and reconstitution of the Loncar Cancer Immunotherapy Index, a group of the top 30 companies developing cancer immunotherapy treatments and...
Management to host conference call today at 8:30 a.m. EDT
Investors considering a purchase of Curis Inc stock, but tentative about paying the going market price of $2.71/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2017 put at the $2.50 strike, which has a bid at the time of this writing of 35 cents.
Curis to issue to 10.2M shares of Common Stock to Aurigene at $2.40 per share